These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 16303243

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics.
    Sugimoto Y, Tsukahara S, Ishikawa E, Mitsuhashi J.
    Cancer Sci; 2005 Aug; 96(8):457-65. PubMed ID: 16108826
    [Abstract] [Full Text] [Related]

  • 3. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.
    Imai Y, Nakane M, Kage K, Tsukahara S, Ishikawa E, Tsuruo T, Miki Y, Sugimoto Y.
    Mol Cancer Ther; 2002 Jun; 1(8):611-6. PubMed ID: 12479221
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.
    Nakamura Y, Oka M, Soda H, Shiozawa K, Yoshikawa M, Itoh A, Ikegami Y, Tsurutani J, Nakatomi K, Kitazaki T, Doi S, Yoshida H, Kohno S.
    Cancer Res; 2005 Feb 15; 65(4):1541-6. PubMed ID: 15735043
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Breast cancer resistance protein exports sulfated estrogens but not free estrogens.
    Imai Y, Asada S, Tsukahara S, Ishikawa E, Tsuruo T, Sugimoto Y.
    Mol Pharmacol; 2003 Sep 15; 64(3):610-8. PubMed ID: 12920197
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH, Li G, Yu J, Xu MS, Liu ZX.
    Zhonghua Zhong Liu Za Zhi; 2011 Sep 15; 33(9):654-60. PubMed ID: 22340044
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.
    Zhang Y, Wang H, Wei L, Li G, Yu J, Gao Y, Gao P, Zhang X, Wei F, Yin D, Zhou G.
    Breast Cancer Res Treat; 2010 Oct 15; 123(3):679-89. PubMed ID: 19967559
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists.
    Sugimoto Y, Tsukahara S, Imai Y, Sugimoto Y, Ueda K, Tsuruo T.
    Mol Cancer Ther; 2003 Jan 15; 2(1):105-12. PubMed ID: 12533678
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship.
    Katayama K, Masuyama K, Yoshioka S, Hasegawa H, Mitsuhashi J, Sugimoto Y.
    Cancer Chemother Pharmacol; 2007 Nov 15; 60(6):789-97. PubMed ID: 17345086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.